The US Court of Appeals for the Federal Circuit has affirmed a district court’s claim construction and grant of a preliminary injunction in a pharmaceutical patent case. The ruling came in Otsuka
More
The FTSE 100 outperformed the S&P 500 in 2025, returning 21.5% versus 16.2%, despite containing almost no pure-play artificial intelligence stocks. While global investors pour money into Nvidia and Microsoft, traditional UK
More
AstraZeneca plc (LON: AZN) fell 1.3 percent and GSK plc (LON: GSK) dropped 1.5 percent on Tuesday April 21, making the pharmaceutical sector the weakest performer in the FTSE 100 as investors
More
Australia-based biotech Propanc Biopharma has announced a major step into the digital asset space with plans to establish a crypto treasury. The company revealed it has secured up to $100 million from
More
The U.S. Food and Drug Administration (FDA) recently withheld approval for a novel once-a-month injection designed to treat relapsing forms of multiple sclerosis (MS), a severe neurological disorder. This decision impacts the
More